Mounjaro (Tirzepatide) Injection 7.5mg

Additional Information

Product Name	Mounjaro (Tirzepatide) Injection 7.5mg
Brand	Eli Lilly and Company
Dosage	7.5 mg / 0.5 mL — subcutaneous injection, once weekly
Description	Mounjaro (tirzepatide) 7.5mg is a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus, and for chronic weight management in adults with obesity. The 7.5mg dose is typically reached after titration from lower doses. Administered as a once-weekly subcutaneous injection, it helps regulate blood sugar and supports significant, sustained weight reduction.
Special Ingredients
Ingredients (All)
Categories	GLP-1 Support & Weight Management
Disclaimer
Longevity Health Co. does not provide medical advice. Customers are advised to consult a licensed healthcare professional before starting any supplement or prescription medication. Products requiring medical supervision should only be used under the guidance of a qualified healthcare professional.